...
首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Results of chest wall reirradiation using pulsed-dose-rate (PDR) brachytherapy molds for breast cancer local recurrences.
【24h】

Results of chest wall reirradiation using pulsed-dose-rate (PDR) brachytherapy molds for breast cancer local recurrences.

机译:使用脉冲剂量率(PDR)近距离放射治疗模具进行胸壁再照射的结果,用于乳腺癌的局部复发。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: We report in a retrospective study on the effect and toxicity of chest wall reirradiation using pulsed-dose-rate (PDR) afterloading molds. METHODS AND MATERIALS: Between 1993 and 1999, a total of 58 patients were treated. All patients presented with locally recurrent breast cancer (31 patients had concomitant distant metastases) after mastectomy and a previously completed course of radiation therapy (median, 54 Gy; range, 36-70). Indication for reirradiation was a progressive macroscopic skin recurrence in 30 cases and an incomplete surgical resection in 28 patients. Standard treatment consisted of a split course with two fractions of 20 Gy (interval, 31 days). The reference dose was prescribed to the skin surface at 5 mm distance from the source. PDR brachytherapy (37 GBq, (192)Ir) was carried out after geometric distance optimization with 0.5-1 Gy/pulse/h. The irradiated median area was 423 cm(2) (range, 100-919). The median follow-up was 18 months (range, 7-84). RESULTS: The actuarial 1-, 2- and 3-year local recurrence-free survival rates in patients treated for macroscopic disease (microscopic disease in parenthesis) were 89% (96%), 81% (85%), and 75% (71%). Local control was obtained in 24/30 (22/28) patients. Twenty-nine of the 34 patients (85%) who deceased during follow-up were locally controlled. 9/58 patients experienced Grade III acute toxicity, 35/58 patients Grade III (29/58 telangiectasia, 6/58 contracture), and 4/58 Grade IV late toxicity (RTOG/EORTC). CONCLUSION: Reirradiation of the chest wall using PDR brachytherapy molds is effective and provides a high local control rate with acceptable toxicity.
机译:目的:我们在回顾性研究中报告了使用脉冲剂量率(PDR)后装模具对胸壁再照射的效果和毒性。方法和材料:从1993年到1999年,共治疗58例患者。所有患者在乳房切除术和先前完成的放射治疗过程后出现局部复发性乳腺癌(31例患者同时发生远处转移)(中位值54 Gy;范围36-70)。再照射的指征是进行性宏观皮肤复发30例,不完全手术切除28例。标准治疗包括分两个疗程(20 Gy)(间隔,31天)。在距放射源5毫米距离处的皮肤表面开出参考剂量。在几何距离优化后以0.5-1 Gy /脉冲/ h进行PDR近距离放射治疗(37 GBq,(192)Ir)。照射的中位面积为423 cm(2)(范围100-919)。中位随访时间为18个月(范围7-84)。结果:在宏观疾病(括号内为微观疾病)的患者中,精算的1年,2年和3年局部无复发生存率分别为89%(96%),81%(85%)和75%( 71%)。在24/30(22/28)位患者中获得了局部对照。随访期间死亡的34例患者中有29例(85%)是局部控制的。 9/58例患者经历了III级急性毒性,35/58例患者发生了III级急性毒性(29/58毛细血管扩张,6/58挛缩)和4/58例IV级晚期毒性(RTOG / EORTC)。结论:使用PDR近距离放射治疗模具对胸壁进行再照射是有效的,并能提供较高的局部控制率和可接受的毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号